MDCX
MDCX
NASDAQ · Biotechnology

Medicus Pharma Ltd

$0.28
-0.07 (-20.88%)
As of Aug 15, 2:29 AM ET ·
Analyst Consensus
Strong Buy
9
Analysts
Moderate
Coverage
Buy 8 89%
Hold 1 11%
Sell 0 0%
Price Target
Analyst Price Target +2,556.2% upside
Low Target $4.65
Average Target $7.44
High Target $8.88
Current Price $0.28
Current
$0.28
Target
$7.44
$4.65 $7.44 avg $8.88
Scenario Analysis
Bear Case
$4.65
1,560.1%
Low target
Base Case
$7.44
+2,556.2%
Avg target
Bull Case
$8.88
+3,070.3%
High target
Risk/Reward
2.0x
Balanced
Price in Context
52-Week High
$3.05
-90.8% from high
52-Week Low
$0.25
+12.0% from low
Target vs 52W High
$7.44
+143.9% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 38 82% $257.58 +3.3%
AMGN
Amgen Inc
Hold 43 49% $190.87 -54.0%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +162.1%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 37 81% $438.34 -13.3%
REGN
Regeneron Pharmaceuticals
Buy 37 70% $76.80 -90.4%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -53.9%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -44.0%
BIIB
Biogen Inc
Buy 43 67% $91.45 -56.4%